Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (321-330 of 489) with videos related to

Pageof 49
Sort By:
Neuroimage|December 20, 2016
In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imagingYue Zhao, Marcus E Raichle, Jie Wen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkersSarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
Journal of Alzheimer'S Disease : JAD|December 13, 2021
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's DiseaseSatya V V N Kothapalli, Tammie L Benzinger, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Brain : a Journal of Neurology|September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levelsYo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Neurology|April 12, 2013
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years laterCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Geriatrics (Basel, Switzerland)|May 29, 2018
Using the A/T/N Framework to Examine Driving in Preclinical ADCatherine M Roe, Ganesh M Babulal, Sarah H Stout, et al.
Pageof 49

Showing results (321-330 of 489) with videos related to

Sort By:
Pageof 49
Neuroimage|December 20, 2016
In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imagingYue Zhao, Marcus E Raichle, Jie Wen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkersSarah H Stout, Ganesh M Babulal, Chunyu Ma, et al.
Journal of Alzheimer'S Disease : JAD|December 13, 2021
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's DiseaseSatya V V N Kothapalli, Tammie L Benzinger, Andrew J Aschenbrenner, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
Brain : a Journal of Neurology|September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levelsYo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Neurology|April 12, 2013
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years laterCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 17, 2020
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndromeRachel L Henson, Eric Doran, Bradley T Christian, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Geriatrics (Basel, Switzerland)|May 29, 2018
Using the A/T/N Framework to Examine Driving in Preclinical ADCatherine M Roe, Ganesh M Babulal, Sarah H Stout, et al.
Pageof 49